Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Timothy Garvey

Showing results (181-190 of 265) with videos related to

Pageof 27
Sort By:
The Journal of Nutrition|April 17, 2009
Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American womenSean H Adams, Charles L Hoppel, Kerry H Lok, et al.
American Journal of Physical Anthropology|March 12, 2005
Mitochondrial DNA genetic diversity among four ethnic groups in Sierra LeoneBruce A Jackson, Jamie Lee Wilson, Salwa Kirbah, et al.
Obesity (Silver Spring, Md.)|January 19, 2023
Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5Sean Wharton, Rachel L Batterham, Meena Bhatta, et al.
The Open Obesity Journal|November 1, 2011
Relationship between Insulin Sensitivity and Muscle Lipids may Differ with Muscle Group and EthnicityJeannine C Lawrence, Barbara A Gower, W Timothy Garvey, et al.
Nature Medicine|October 10, 2022
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trialW Timothy Garvey, Rachel L Batterham, Meena Bhatta, et al.
The New England Journal of Medicine|June 22, 2025
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 DiabetesMelanie J Davies, Harpreet S Bajaj, Christa Broholm, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 27, 2010
Genes and biochemical pathways in human skeletal muscle affecting resting energy expenditure and fuel partitioningXuxia Wu, Amit Patki, Cristina Lara-Castro, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2010
Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetesJulio Rosenstock, Vivian A Fonseca, W Timothy Garvey, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2010
Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective studyYehuda Handelsman, Ronald B Goldberg, W Timothy Garvey, et al.
Obesity (Silver Spring, Md.)|May 23, 2020
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5Robert F Kushner, Salvatore Calanna, Melanie Davies, et al.
Pageof 27

Showing results (181-190 of 265) with videos related to

Sort By:
Pageof 27
The Journal of Nutrition|April 17, 2009
Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American womenSean H Adams, Charles L Hoppel, Kerry H Lok, et al.
American Journal of Physical Anthropology|March 12, 2005
Mitochondrial DNA genetic diversity among four ethnic groups in Sierra LeoneBruce A Jackson, Jamie Lee Wilson, Salwa Kirbah, et al.
Obesity (Silver Spring, Md.)|January 19, 2023
Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5Sean Wharton, Rachel L Batterham, Meena Bhatta, et al.
The Open Obesity Journal|November 1, 2011
Relationship between Insulin Sensitivity and Muscle Lipids may Differ with Muscle Group and EthnicityJeannine C Lawrence, Barbara A Gower, W Timothy Garvey, et al.
Nature Medicine|October 10, 2022
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trialW Timothy Garvey, Rachel L Batterham, Meena Bhatta, et al.
The New England Journal of Medicine|June 22, 2025
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 DiabetesMelanie J Davies, Harpreet S Bajaj, Christa Broholm, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 27, 2010
Genes and biochemical pathways in human skeletal muscle affecting resting energy expenditure and fuel partitioningXuxia Wu, Amit Patki, Cristina Lara-Castro, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2010
Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetesJulio Rosenstock, Vivian A Fonseca, W Timothy Garvey, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2010
Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective studyYehuda Handelsman, Ronald B Goldberg, W Timothy Garvey, et al.
Obesity (Silver Spring, Md.)|May 23, 2020
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5Robert F Kushner, Salvatore Calanna, Melanie Davies, et al.
Pageof 27